Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Azitra's annualizedGross Profit for the quarter that ended in Sep. 2024 was $0.00 Mil.
Azitra's average Total Assets over the quarter that ended in Sep. 2024 was $6.83 Mil. Therefore, Azitra's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 0.00%.
Azitra Gross-Profit-to-Asset % Historical Data
The historical data trend for Azitra's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Azitra's Gross-Profit-to-Asset %
For the Biotechnology subindustry, Azitra's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Azitra's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Azitra's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Azitra's Gross-Profit-to-Asset % falls into.
Azitra Gross-Profit-to-Asset % Calculation
Azitra's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Sep. 2024) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Azitra Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Azitra's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AZTR has been successfully added to your 